META : Jefferies maintains a Buy ratingAlready positive, the research from Jefferies and its analyst Brent Thill still consider the stock as a Buy opportunity. The target price is lowered from USD 585 to USD 540.
StockNews.com upgraded shares of Blackbaud (NASDAQ:BLKB – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning. Separately, Robert W. Baird decreased their target price on shares of Blackbaud from $95.00 to $88.00 and set an outperform rating for the company in a research report on Wednesday, […]
StockNews.com upgraded shares of APA (NASDAQ:APA – Free Report) from a hold rating to a buy rating in a research note published on Tuesday. Several other equities research analysts also recently weighed in on APA. Barclays began coverage on shares of APA in a research note on Wednesday, April 10th. They issued an equal weight […]
StockNews.com upgraded shares of Crane (NYSE:CR – Free Report) from a hold rating to a buy rating in a research note released on Saturday. A number of other research analysts have also recently commented on the stock. Stifel Nicolaus boosted their target price on shares of Crane from $150.00 to $157.00 and gave the stock […]
Ever since mortgage interest rates jumped in 2022, some Californians have had a strategy: Buy now and, once rates drop, refinance to save hundreds of dollars each month. The idea — pushed by some real estate agents — was supposed to be a trade-off. The buyer could pick up a home in a slower market, and though interest costs would be high, they wouldn’t stay that way. The strategy may still work, but so far, high borrowing costs are here to stay. In recent weeks, rates have climbed higher,...
Colony Bankcorp (NASDAQ:CBAN – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. Colony Bankcorp Price Performance Shares of NASDAQ CBAN traded up $0.07 during trading on Monday, hitting $10.70. The company had a trading volume of 17,647 shares, […]
Tesla, Inc.'s price decline attributed to competition, price cuts, and delayed Model 2. With Q2 earnings on tap, we discuss TSLA prospects and my buying strategy.
NEW YORK >> U.S. stocks closed mixed today after the Federal Reserve left its key interest rate unchanged, as expected, and indicated that while its next move will likely be a rate cut, continued progress on inflation is not assured.
Leerink Partnrs reiterated their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a research report sent to investors on Tuesday morning, Zacks.com reports. Leerink Partnrs also issued estimates for Cartesian Therapeutics’ Q1 2024 earnings at ($1.34) EPS, Q2 2024 earnings at ($1.38) EPS, Q3 2024 earnings at ($1.27) EPS, Q4 2024 […]
The Bank of Japan has decided to keep its monetary policy framework unchanged, as widely expected. The central bank held its interest rate settings steady, while it dropped a reference to buying roughly the same amount of government bonds as previously. Haslinda Amin reports on Bloomberg Television.
Bfsg LLC bought a new stake in shares of ASML Holding (NASDAQ:ASML – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 488 shares of the semiconductor company’s stock, valued at approximately $369,000. A number of other institutional investors and hedge funds have […]
Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a report on Monday, March 25th. They set a “buy” rating and a $10.00 […]